Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 31  Show

Literature citations Results

Citation
XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency.

Guo C., Nakazawa Y., Woodbine L., Bjoerkman A., Shimada M., Fawcett H., Jia N., Ohyama K., Li T.S., Nagayama Y. et al.

J. Allergy Clin. Immunol. 136:1007-1017(2015) · UniProtKB (1)

Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis.

Bavoux C., Leopoldino A.M., Bergoglio V., O-Wang J., Ogi T., Bieth A., Judde J.G., Pena S.D., Poupon M.F., Helleday T. et al.

Cancer Res. 65:325-330(2005) · Mapped (13)

Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly.

Matsumoto Y., Miyamoto T., Sakamoto H., Izumi H., Nakazawa Y., Ogi T., Tahara H., Oku S., Hiramoto A., Shiiki T. et al.

DNA Repair (Amst.) 10:314-321(2011) · Mapped (7)

Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells.

Ogi T., Limsirichaikul S., Overmeer R.M., Volker M., Takenaka K., Cloney R., Nakazawa Y., Niimi A., Miki Y., Jaspers N.G. et al.

Mol. Cell 37:714-727(2010) · UniProtKB (6) · Mapped (64)

The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair.

Ogi T., Lehmann A.R.

Nat. Cell Biol. 8:640-642(2006) · Mapped (15)

The absence of DNA polymerase kappa does not affect somatic hypermutation of the mouse immunoglobulin heavy chain gene.

Shimizu T., Shinkai Y., Ogi T., Ohmori H., Azuma T.

Immunol. Lett. 86:265-270(2003) · Mapped (16)

PRKDC mutations in a SCID patient with profound neurological abnormalities.

Woodbine L., Neal J.A., Sasi N.K., Shimada M., Deem K., Coleman H., Dobyns W.B., Ogi T., Meek K., Davies E.G. et al.

J. Clin. Invest. 123:2969-2980(2013) · UniProtKB (1) · Mapped (1)

Pol kappa protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene.

Ogi T., Shinkai Y., Tanaka K., Ohmori H.

Proc. Natl. Acad. Sci. U.S.A. 99:15548-15553(2002) · UniProtKB (1) · Mapped (15)

Phosphorylated HBO1 at UV irradiated sites is essential for nucleotide excision repair.

Niida H., Matsunuma R., Horiguchi R., Uchida C., Nakazawa Y., Motegi A., Nishimoto K., Sakai S., Ohhata T., Kitagawa K. et al.

Nat Commun 8:16102-16102(2017) · Mapped (6)

PCNA ubiquitylation ensures timely completion of unperturbed DNA replication in fission yeast.

Daigaku Y., Etheridge T.J., Nakazawa Y., Nakayama M., Watson A.T., Miyabe I., Ogi T., Osborne M.A., Carr A.M.

PLoS Genet. 13:e1006789-e1006789(2017) · Mapped (7)

Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair.

Nakazawa Y., Sasaki K., Mitsutake N., Matsuse M., Shimada M., Nardo T., Takahashi Y., Ohyama K., Ito K., Mishima H. et al.

Nat. Genet. 44:586-592(2012) · UniProtKB (3) · Mapped (43)

Mutation enhancement by DINB1, a mammalian homologue of the Escherichia coli mutagenesis protein dinB.

Ogi T., Kato T. Jr., Kato R., Ohmori H.

Genes Cells 4:607-618(1999) · UniProtKB (2) · Mapped (15)

[Molecular cloning and characterisation of UVSSA, the responsible gene for UV-sensitive syndrome].

Ogi T., Nakazawa Y., Sasaki K., Guo C., Yoshiura K., Utani A., Nagayama Y.

Seikagaku 85:133-144(2013) · Mapped (2)

Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.

Kashiyama K., Nakazawa Y., Pilz D.T., Guo C., Shimada M., Sasaki K., Fawcett H., Wing J.F., Lewin S.O., Carr L. et al.

Am. J. Hum. Genet. 92:807-819(2013) · UniProtKB (2) · Mapped (9)

Localisation of human Y-family DNA polymerase kappa: relationship to PCNA foci.

Ogi T., Kannouche P., Lehmann A.R.

J. Cell. Sci. 118:129-136(2005) · Mapped (5)

Involvement of vertebrate Polkappa in translesion DNA synthesis across DNA monoalkylation damage.

Takenaka K., Ogi T., Okada T., Sonoda E., Guo C., Friedberg E.C., Takeda S.

J. Biol. Chem. 281:2000-2004(2006) · Mapped (15)

Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome.

Ogi T., Walker S., Stiff T., Hobson E., Limsirichaikul S., Carpenter G., Prescott K., Suri M., Byrd P.J., Matsuse M. et al.

PLoS Genet. 8:e1002945-e1002945(2012) · Mapped (5)

Identification of additional genes belonging to the LexA regulon in Escherichia coli.

Fernandez De Henestrosa A.R., Ogi T., Aoyagi S., Chafin D., Hayes J.J., Ohmori H., Woodgate R.

Mol. Microbiol. 35:1560-1572(2000) · UniProtKB (12)

Hypomorphic PCNA mutation underlies a human DNA repair disorder.

Baple E.L., Chambers H., Cross H.E., Fawcett H., Nakazawa Y., Chioza B.A., Harlalka G.V., Mansour S., Sreekantan-Nair A., Patton M.A. et al.

J. Clin. Invest. 124:3137-3146(2014) · UniProtKB (2) · Mapped (7)

Hydrogel-mediated release of basic fibroblast growth factor from a stent-graft accelerates biological fixation with the aortic wall in a porcine model.

Kusanagi M., Matsui O., Sanada J., Ogi T., Takamatsu S., Zhong H., Kimura Y., Tabata Y.

J. Endovasc. Ther. 14:785-793(2007) · Mapped (2)

Functional characterization of the novel BRAF complex mutation, BRAF(V600delinsYM) , identified in papillary thyroid carcinoma.

Matsuse M., Mitsutake N., Tanimura S., Ogi T., Nishihara E., Hirokawa M., Fuziwara C.S., Saenko V.A., Suzuki K., Miyauchi A. et al.

Int. J. Cancer 132:738-743(2013) · Mapped (1)

Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome.

Calmels N., Botta E., Jia N., Fawcett H., Nardo T., Nakazawa Y., Lanzafame M., Moriwaki S., Sugita K., Kubota M. et al.

J. Med. Genet. 55:329-343(2018) · Mapped (15)

Expression of human and mouse genes encoding polkappa: testis-specific developmental regulation and AhR-dependent inducible transcription.

Ogi T., Mimura J., Hikida M., Fujimoto H., Fujii-Kuriyama Y., Ohmori H.

Genes Cells 6:943-953(2001) · Mapped (72)

Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa.

Ohashi E., Ogi T., Kusumoto R., Iwai S., Masutani C., Hanaoka F., Ohmori H.

Genes Dev. 14:1589-1594(2000) · Mapped (17)

Elevated expression of DNA polymerase kappa in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53.

Wang Y., Seimiya M., Kawamura K., Yu L., Ogi T., Takenaga K., Shishikura T., Nakagawara A., Sakiyama S., Tagawa M. et al.

Int. J. Oncol. 25:161-165(2004) · Mapped (197)

1 to 25 of 31  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again